We are live on ! Find out more
ECM

Everence Capital Management Portfolio holdings

AUM $1.9B
1-Year Est. Return 39.77%
This Fund
S&P 500
This Quarter Est. Return
+7.88%
1 Year Est. Return
+39.77%
3 Year Est. Return
+108.07%
5 Year Est. Return
+139.85%
10 Year Est. Return
+551.6%
AUM
$1.16M
AUM Growth
-$1.08B
Cap. Flow
+$4.02M
Cap. Flow %
346.58%
Top 10 Hldgs %
29.07%
Holding
823
New
103
Increased
158
Reduced
175
Closed
78

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$5.14M
2
CBRE icon
CBRE Group
CBRE
+$4.74M
3
LIN icon
Linde
LIN
+$3.18M
4
ADBE icon
Adobe
ADBE
+$2.58M
5
SLB icon
SLB Ltd
SLB
+$2.49M

Sector Composition

Rank Sector Weight
1 Technology 19.44%
2 Healthcare 12.87%
3 Financials 11.36%
4 Consumer Discretionary 7.93%
5 Industrials 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFC icon
101
Truist Financial
TFC
$64.2B
$2.14K 0.18%
49,760
+9,100
+22% +$399K
BDX icon
102
Becton Dickinson
BDX
$48.8B
$2.11K 0.18%
8,310
BKNG icon
103
Booking.com
BKNG
$156B
$2.04K 0.18%
25,250
-1,125
-4% -$85.4K
NOW icon
104
ServiceNow
NOW
$121B
$2.03K 0.17%
26,115
-9,650
-27% -$754K
PYPL icon
105
PayPal
PYPL
$51.1B
$2.01K 0.17%
28,270
-11,217
-28% -$898K
FISV
106
Fiserv Inc
FISV
$28.9B
$2K 0.17%
19,746
-1,620
-8% -$161K
ZTS icon
107
Zoetis
ZTS
$32.4B
$1.99K 0.17%
13,590
-130
-0.9% -$19.2K
OTIS icon
108
Otis Worldwide
OTIS
$28.1B
$1.99K 0.17%
25,430
+6,540
+35% +$483K
CB icon
109
Chubb
CB
$137B
$1.96K 0.17%
8,860
+4,320
+95% +$899K
BSX icon
110
Boston Scientific
BSX
$71.4B
$1.91K 0.16%
41,210
+12,030
+41% +$521K
ADI icon
111
Analog Devices
ADI
$184B
$1.9K 0.16%
11,564
-1,330
-10% -$208K
GWW icon
112
W.W. Grainger
GWW
$60.4B
$1.89K 0.16%
3,400
+2,090
+160% +$1.18M
MRSH
113
Marsh
MRSH
$92.2B
$1.89K 0.16%
11,410
+2,020
+22% +$330K
CME icon
114
CME Group
CME
$95.1B
$1.88K 0.16%
11,190
-190
-2% -$33K
GPC icon
115
Genuine Parts
GPC
$18.3B
$1.86K 0.16%
10,710
+6,140
+134% +$1.07M
NSC icon
116
Norfolk Southern
NSC
$76.9B
$1.77K 0.15%
7,190
PNC icon
117
PNC Financial Services
PNC
$101B
$1.76K 0.15%
11,131
-1,940
-15% -$305K
BNY
118
Bank of New York Mellon
BNY
$108B
$1.73K 0.15%
38,024
MET icon
119
MetLife
MET
$64.4B
$1.72K 0.15%
23,733
-11,680
-33% -$837K
ATVI
120
DELISTED
Activision Blizzard
ATVI
$1.71K 0.15%
22,370
-2,190
-9% -$163K
CDNS icon
121
Cadence Design Systems
CDNS
$93.2B
$1.71K 0.15%
10,624
KEYS icon
122
Keysight
KEYS
$57.6B
$1.7K 0.15%
9,911
-2,310
-19% -$394K
DG icon
123
Dollar General
DG
$28.1B
$1.68K 0.14%
6,823
+740
+12% +$183K
ISRG icon
124
Intuitive Surgical
ISRG
$132B
$1.67K 0.14%
6,300
-1,470
-19% -$358K
AON icon
125
Aon
AON
$76.5B
$1.66K 0.14%
5,540
+4,280
+340% +$1.25M

Similar funds

Everence Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Everence Capital Management held 823 positions worth $1.16M, down 100% from $1.08B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Everence Capital Management deployed $4.02M of net new capital in Q4 2022, opening 103 new positions and adding to 158 existing holdings. Its largest new stake was TransDigm Group: 2,380 shares worth $1.5K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Apple, an estimated $5.14M trimmed.

  • Everence Capital Management's largest Q4 2022 buy was TransDigm Group: 2,380 shares worth $1.5K.
  • Everence Capital Management added most to Pioneer Natural Resource Co. in Q4 2022, an estimated $9.88M increase.
  • Everence Capital Management's biggest Q4 2022 reduction was Apple, cutting an estimated $5.14M.
  • Everence Capital Management fully exited Fortinet in Q4 2022, selling an estimated $1.32M.
  • Everence Capital Management's ten largest holdings make up 29% of its $1.16M portfolio in Q4 2022.
  • Everence Capital Management opened 103 new positions and closed 78 in Q4 2022.
  • Everence Capital Management's portfolio value fell 100% quarter-over-quarter to $1.16M.

Based on Everence Capital Management's 13F filing for Q4 2022, filed 31 Jan 2023.